INCREASED DIETARY INTAKE AND SERUM LEVELS OF ADVANCED GLYCATION END PRODUCTS (AGES) ARE ASSOCIATED WITH DIABETIC MACULAR EDEMA
- PMID: 36699179
- PMCID: PMC9867808
- DOI: 10.4183/aeb.2022.278
INCREASED DIETARY INTAKE AND SERUM LEVELS OF ADVANCED GLYCATION END PRODUCTS (AGES) ARE ASSOCIATED WITH DIABETIC MACULAR EDEMA
Abstract
Aim: Diabetic macular oedema (DME) can develop at all stages of diabetic retinopathy, causing visual impairment and blindness. Modern diets are high in advanced glycation end products (dAGEs), derived from processing methods, exerting a pivotal role in promoting diabetic retinopathy risk. In present study, we investigate the relationship between dietary and serum levels of AGEs and DME in type 2 diabetic subjects.
Methods: This case-control study was conducted between July 2018 and February 2019 on 50 case subjects with DME and 40 healthy controls without DM without DME. The sociodemographic characteristics, nutritional status, and anthropometric measurements were evaluated. The advanced glycation end products (AGEs) and receptor for AGEs (sRAGE) levels in serum were analysed.
Results: The AGEs levels of the DME group were higher than in the control group (p <0.05). sRAGE levels were higher in the DME group, but not statistically significant (p >0.05). The dietary intake of AGEs was higher in the DME group (p <0.05). It was found that an increase in neck circumference increased the risk of DME (p <0.001).
Conclusion: A positive correlation was found between DME and AGEs, dAGE, neck circumference, and waist circumference. For the validity of these results, studies, including controlled nutrition interventions, are needed.
Keywords: AGEs; diabetic macular edema; dietary advanced glycation end products; nutrition; sRAGE.
©2022 Acta Endocrinologica (Buc).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.Nutr Metab Cardiovasc Dis. 2017 Nov;27(11):978-984. doi: 10.1016/j.numecd.2017.06.014. Epub 2017 Jul 8. Nutr Metab Cardiovasc Dis. 2017. PMID: 28958695
-
Elevated advanced glycation end products are associated with subfoveal ellipsoid zone disruption in diabetic macular edema.Indian J Ophthalmol. 2021 Nov;69(11):3199-3202. doi: 10.4103/ijo.IJO_1244_21. Indian J Ophthalmol. 2021. PMID: 34708772 Free PMC article.
-
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13. Diabetologia. 2006. PMID: 16969649
-
Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.Adv Nutr. 2021 Dec 1;12(6):2157-2171. doi: 10.1093/advances/nmab072. Adv Nutr. 2021. PMID: 34139010 Free PMC article.
-
Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.Curr Drug Targets. 2007 Oct;8(10):1138-43. doi: 10.2174/138945007782151298. Curr Drug Targets. 2007. PMID: 17979674 Review.
References
-
- King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes care. 1993;16(1):157–177. - PubMed
LinkOut - more resources
Full Text Sources